Finnish researchers have developed a device that assists in identifying cancerous tissue during surgery, thereby reducing the risk of disease recurrence.
The device to reduce cancer recurrence risk has been clinically tested at Kuopio University Hospital – (Photo: Moffitt).
The device is attached to a surgical suction tube and identifies tumor tissue. Surgeons will continuously monitor information about cancer tissue cells, allowing them to remove this tissue from the human body.
This device was developed by the University of Eastern Finland, the neurosurgery department of Kuopio University Hospital, and the Eastern Finland Microsurgery Center, in collaboration with the startup company Marginum.
The implementation of this device will improve tumor removal rates and reduce the need for reoperation, while also helping to save costs and provide better outcomes for cancer patients.
Antti-Pekka Elomaa, an associate professor of experimental neurosurgery and chairman of the Marginum board, expressed hope that in the near future, the technique for monitoring cancer tissue could be improved to become the “gold standard” for developing surgical methods using fluorescence.
Cancer is currently the second leading cause of death worldwide. In Vietnam, it is estimated that there are 182,563 new cases and 122,690 cancer-related deaths each year. For every 100,000 people, there are 159 new cancer diagnoses and 106 deaths due to cancer.
